Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases

Abstract Fetal liver hematopoietic stem cells (HSCs) have the capacity to temporarily engraft, thereby facilitating the reconstitution of hematopoiesis without severe graft-versus-host disease (GVHD). In two cases of acute leukemia, the patients underwent fetal liver transplantation (FLT), receiving...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing-wen Niu, Jiangwei Hu, Hu Chen, Bin Zhang, Liangding Hu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-024-04119-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850067924994228224
author Jing-wen Niu
Jiangwei Hu
Hu Chen
Bin Zhang
Liangding Hu
author_facet Jing-wen Niu
Jiangwei Hu
Hu Chen
Bin Zhang
Liangding Hu
author_sort Jing-wen Niu
collection DOAJ
description Abstract Fetal liver hematopoietic stem cells (HSCs) have the capacity to temporarily engraft, thereby facilitating the reconstitution of hematopoiesis without severe graft-versus-host disease (GVHD). In two cases of acute leukemia, the patients underwent fetal liver transplantation (FLT), receiving cells from multiple donors at doses ranging from 7.02 to 8.3 × 10^8 cells/kg, following an intensive conditioning regimen in 1983 and 1985. Remarkably, both individuals have since achieved sustained complete remission and hematopoietic recovery, and have maintained a normal life for over three decades. Although FLT is no longer a viable clinical option, the positive outcomes of these cases are noteworthy and are shared herein. Our findings underscore the potential of FLT to offer short-term hematopoietic support, contributing to the recovery of patients with acute leukemia and may inspire research into ideal HSCs that emulate the characteristics of fetal liver cells for future transplantation applications.
format Article
id doaj-art-441d2bbe70504f4f87ffe50dbe965177
institution DOAJ
issn 1757-6512
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj-art-441d2bbe70504f4f87ffe50dbe9651772025-08-20T02:48:11ZengBMCStem Cell Research & Therapy1757-65122025-02-011611510.1186/s13287-024-04119-yLong-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two casesJing-wen Niu0Jiangwei Hu1Hu Chen2Bin Zhang3Liangding Hu4Senior Department of Hematology, the Fifth Medical Center of PLA General HospitalSenior Department of Hematology, the Fifth Medical Center of PLA General HospitalSenior Department of Hematology, the Fifth Medical Center of PLA General HospitalSenior Department of Hematology, the Fifth Medical Center of PLA General HospitalSenior Department of Hematology, the Fifth Medical Center of PLA General HospitalAbstract Fetal liver hematopoietic stem cells (HSCs) have the capacity to temporarily engraft, thereby facilitating the reconstitution of hematopoiesis without severe graft-versus-host disease (GVHD). In two cases of acute leukemia, the patients underwent fetal liver transplantation (FLT), receiving cells from multiple donors at doses ranging from 7.02 to 8.3 × 10^8 cells/kg, following an intensive conditioning regimen in 1983 and 1985. Remarkably, both individuals have since achieved sustained complete remission and hematopoietic recovery, and have maintained a normal life for over three decades. Although FLT is no longer a viable clinical option, the positive outcomes of these cases are noteworthy and are shared herein. Our findings underscore the potential of FLT to offer short-term hematopoietic support, contributing to the recovery of patients with acute leukemia and may inspire research into ideal HSCs that emulate the characteristics of fetal liver cells for future transplantation applications.https://doi.org/10.1186/s13287-024-04119-yFetal liver transplantation (FLT)Acute leukemiaHematopoietic stem cells (HSCs)Graft-versus-host disease (GVHD)Long-term remission
spellingShingle Jing-wen Niu
Jiangwei Hu
Hu Chen
Bin Zhang
Liangding Hu
Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases
Stem Cell Research & Therapy
Fetal liver transplantation (FLT)
Acute leukemia
Hematopoietic stem cells (HSCs)
Graft-versus-host disease (GVHD)
Long-term remission
title Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases
title_full Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases
title_fullStr Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases
title_full_unstemmed Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases
title_short Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases
title_sort long term remission after fetal liver transplantation in acute leukemia a 30 year follow up report of two cases
topic Fetal liver transplantation (FLT)
Acute leukemia
Hematopoietic stem cells (HSCs)
Graft-versus-host disease (GVHD)
Long-term remission
url https://doi.org/10.1186/s13287-024-04119-y
work_keys_str_mv AT jingwenniu longtermremissionafterfetallivertransplantationinacuteleukemiaa30yearfollowupreportoftwocases
AT jiangweihu longtermremissionafterfetallivertransplantationinacuteleukemiaa30yearfollowupreportoftwocases
AT huchen longtermremissionafterfetallivertransplantationinacuteleukemiaa30yearfollowupreportoftwocases
AT binzhang longtermremissionafterfetallivertransplantationinacuteleukemiaa30yearfollowupreportoftwocases
AT liangdinghu longtermremissionafterfetallivertransplantationinacuteleukemiaa30yearfollowupreportoftwocases